DOI: 10.1038/s41467-020-14670-w; PMCID: PMC7031230
Eliciting protective titers of HIV-1 broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development, but current vaccine strategies have yet to induce bnAbs in humans. Many bnAbs isolated from HIV-1-infected individuals are encoded by immunoglobulin gene rearrangments with infrequent naive B cell precursors and with unusual genetic features that may be subject to host regulatory control. Here, we administer antibodies targeting immune cell regulatory receptors CTLA-4, PD-1 or OX40 along with HIV envelope (Env) vaccines to rhesus macaques and bnAb immunoglobulin knock-in (KI) mice expressing diverse precursors of CD4 binding site HIV-1 bnAbs. CTLA-4 blockade augments HIV-1 Env antibody responses in macaques, and in a bnAb-precursor mouse model, CTLA-4 blocking or OX40 agonist antibodies increase germinal center B and T follicular helper cells and plasma neutralizing antibodies. Thus, modulation of CTLA-4 or OX40 immune checkpoints during vaccination can promote germinal center activity and enhance HIV-1 Env antibody responses.
AIDS Vaccines; Animals; Antibodies, Blocking; Antibodies, Neutralizing; B-Lymphocytes; CD4 Antigens; CTLA-4 Antigen; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunologic Factors; Lymphocyte Activation; Macaca mulatta; Mice; Mice, Transgenic; Receptors, OX40; T-Lymphocytes, Helper-Inducer; Transcriptome; Vaccination; env Gene Products, Human Immunodeficiency Virus
AIDS Vaccines; Blocking Antibodies; Neutralizing Antibodies; B-Lymphocytes; CD4 Antigens; CTLA-4 Antigen; HIV Antibodies; HIV Infections; HIV-1; Immunologic Factors; Lymphocyte Activation; Macaca mulatta; Receptors, OX40; T-Lymphocytes, Helper-Inducer; Transcriptome; Vaccination; env Gene Products, Human Immunodeficiency Virus
Bradley T, Kuraoka M, Yeh CH, et al. Immune checkpoint modulation enhances HIV-1 antibody induction. Nat Commun. 2020;11(1):948. Published 2020 Feb 19. doi:10.1038/s41467-020-14670-w
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Link: https://www.nature.com/articles/s41467-020-14670-w